Skip to main content

Triferic AVNU Side Effects

Generic name: ferric pyrophosphate

Medically reviewed by Drugs.com. Last updated on Jan 24, 2024.

Note: This document contains side effect information about ferric pyrophosphate. Some dosage forms listed on this page may not apply to the brand name Triferic AVNU.

Applies to ferric pyrophosphate: route not applicable powder for solution, route not applicable solution.

Serious side effects of Triferic AVNU

Along with its needed effects, ferric pyrophosphate (the active ingredient contained in Triferic AVNU) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ferric pyrophosphate:

More common

Less common

Incidence not known

Other side effects of Triferic AVNU

Some side effects of ferric pyrophosphate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Other side effects of Triferic AVNU

Some side effects of ferric pyrophosphate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For Healthcare Professionals

Applies to ferric pyrophosphate: parenteral powder for injection, parenteral solution.

Cardiovascular

Very common (10% or more): Procedural hypotension (21.6%)

Common (1% to 10%): Arteriovenous fistula thrombosis, arteriovenous fistula sight hemorrhage

Frequency not reported: Intradialytic hypotension[Ref]

Nervous system

Common (1% to 10%): Headache

Frequency not reported: Dizziness[Ref]

Other

Common (1% to 10%): Peripheral edema, pyrexia, asthenia, fatigue[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity[Ref]

Respiratory

Common (1% to 10%): Dyspnea[Ref]

Immunologic

Common (1% to 10%): Urinary tract infection[Ref]

Gastrointestinal

Frequency not reported: Constipation, nausea[Ref]

Dermatologic

Frequency not reported: Pruritus[Ref]

Musculoskeletal

Common (1% to 10%): Muscle spasms, pain in extremity, back pain[Ref]

References

1. Product Information. Voraxaze (glucarpidase). BTG International Inc. 2012.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.